Skip to main content
Sean Pittock, MD, Neurology, Rochester, MN

Sean J Pittock MD

Hospital/Neurohospitalist


Professor, Neurology, Mayo Medical School

Join to View Full Profile
  • 200 1st St SwRochester, MN 55905

  • Phone+1 507-284-2511

Dr. Pittock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2003
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1999 - 2002
  • University College of Dublin National Univ SOM
    University College of Dublin National Univ SOMClass of 1993

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2001 - 2025
  • OK State Medical License
    OK State Medical License 2017 - 2024
  • CT State Medical License
    CT State Medical License 2017 - 2023
  • TN State Medical License
    TN State Medical License 2016 - 2023
  • IL State Medical License
    IL State Medical License 2014 - 2020
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated Disorders  
    Amy Kunchok, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittock, JAMA Neurology
  • Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis  
    Divyanshu Dubey, John Cheville, Thomas Kryzer, Chadwick Hales, Jorge Kattah, Eoin P Flanagan, Anastasia Zekeridou, Jenny J Linnoila, Andrew Mckeon, Sean J Pittock, JAMA Neurology
  • Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events  
    Amy Kunchok, Allen J Aksamit, Sean J Pittock, Brian G Weinshenker, Andrew Mckeon, JAMA Neurology
  • Join now to see all

Authored Content

  • Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAugust 2020
  • Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020
  • Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020
  • Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsMay 2020
  • Scientists Discover Autoimmune Disease Associated with Testicular CancerJuly 2019
  • Join now to see all

Press Mentions

  • 48 36 (75.0%) 12 (25.0%)
    48 36 (75.0%) 12 (25.0%)August 19th, 2022
  • AstraZeneca's Ultomiris Hits Primary Endpoint for PhIII NMOSD Study
    AstraZeneca's Ultomiris Hits Primary Endpoint for PhIII NMOSD StudyMay 5th, 2022
  • Ultomiris Met Primary Endpoint in CHAMPION-NMOSD Phase III Trial in Adults with Neuromyelitis Optica Spectrum Disorder
    Ultomiris Met Primary Endpoint in CHAMPION-NMOSD Phase III Trial in Adults with Neuromyelitis Optica Spectrum DisorderMay 5th, 2022
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: